Stocks
AstraZeneca PLC (AZN) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 20.2% | 20.2% | 21.0% | 21.0% | 30.4% | 30.2% | ||
| Changes by years, y/y, % | -11pp | 0pp | +1pp | 0pp | +9pp | -1.3% | |||
AstraZeneca PLC. EBITDA margin, %
AstraZeneca PLC. EBITDA margin, changes, pp
AstraZeneca PLC (AZN) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA margin, % | ? | 22.1% | 28.9% | 24.2% | 35.5% | 31.8% | 30.2% | |
| Changes by years, y/y, % | +4pp | +4pp | +14pp | 0pp | +10pp | |||
| Changes by quarters, q/q, % | -14pp | +7pp | -5pp | +11pp | -4pp | |||
